Terry Smith

Terry Smith is the founder, CEO, and CIO of Fundsmith, a London-based investment management firm he launched in 2010. Before founding Fundsmith, Smith had a distinguished career in the City of London: he was a top-rated banking analyst at various brokerages in the 1980s, became CEO of Collins Stewart (a stockbroking firm) in 2003, and authored the influential book 'Accounting for Growth' (1992), which exposed aggressive accounting practices at major UK companies -- the book was so controversial that his employer at the time (UBS Phillips & Drew) fired him for it, and several of the companies he criticized subsequently went bankrupt, vindicating his analysis. This episode cemented his reputation as a fearless, independent thinker. Fundsmith Equity Fund launched in November 2010 with the radical premise (for the UK fund industry at the time) of simplicity: own good businesses, don't overpay, do nothing. The fund grew rapidly on the strength of its performance, reaching over 25 billion GBP in AUM at its peak (making it one of the UK's largest equity funds). As of early 2026, AUM is approximately 20-23 billion GBP. Smith is known for his sharp wit, contrarian streak, and willingness to publicly criticize company management, poor capital allocation, and accounting gimmicks. He is a deeply competitive investor who cares intensely about performance.

Excellent track record since inception. Fundsmith Equity Fund (T Class Accumulation) has compounded at approximately 15-16% annualized from November 2010 through 2024, significantly outperforming the MSCI World Index over the same period. Performance by year has been remarkably consistent: the fund outperformed in most years, with only 2022 (-13.8%) and 2023 being notable underperformance years. The fund's worst calendar year was 2022, when rising interest rates hit the valuations of quality growth stocks. However, 2023-2024 saw strong recovery. Since inception through late 2024, the fund has roughly 7x'd investor capital, turning GBP 1 into approximately GBP 6.80+ (T class accumulation). This represents one of the best track records among major European fund managers over this period. Risk-adjusted returns are strong -- the fund has achieved its returns with lower-than-market drawdowns in most stress episodes (2011 Euro crisis, 2018 Q4, 2020 COVID). However, critics note that (a) the fund's inception coincided with the start of a massive quality/growth bull market, and (b) the fund's heavy US/tech exposure makes it less differentiated from a Nasdaq-tilted passive portfolio than the headline numbers suggest. The fund was also soft-closed at one point due to capacity concerns, though it has since reopened as AUM declined from its peak.

Top holdings as of recent filings include: Meta Platforms (~8-9%), Microsoft (~7-8%), Novo Nordisk (~6-7%), LVMH (~5-6%), Stryker (~4-5%), Philip Morris International (~4-5%), L'Oreal (~4-5%), Visa (~4-5%), IDEXX Laboratories (~3-4%), and Estee Lauder/Waters Corporation/other quality names. Historical core positions include Unilever (sold after public criticism of management), PayPal (sold after deterioration), Facebook/Meta (held through the 2022 drawdown and rewarded handsomely). The portfolio is characterized by high ROCE (aggregate portfolio ROCE typically 25-30%+), high gross margins (typically 60%+), and low capital intensity. Smith explicitly screens for these metrics. His willingness to hold Meta through its 2022 crash and increase his position demonstrated genuine conviction and long-term thinking.

Terry Smith is highly relevant to our approach. His 'buy good companies, don't overpay, do nothing' philosophy aligns closely with our focus on quality compounders held for the long term. His concentration level (25-30 positions) is somewhat higher than our ideal but still concentrated by industry standards. His forensic accounting background is directly applicable to our 'balance sheet deep dive' analysis area. His emphasis on high ROCE, FCF generation, and management quality matches our framework. His portfolio includes several AGI-relevant names (Meta, Microsoft) but his selection is based on quality metrics rather than explicit AGI thesis. His annual letters and shareholder presentations are excellent educational material. Key gaps: (1) his portfolio is larger (25-30 positions) than our ideal (5-10); (2) he does not explicitly consider AGI disruption risk/opportunity; (3) his style has somewhat correlated with the growth factor, meaning his outperformance may partially reflect a factor bet rather than pure stock selection; (4) his ego and combativeness, while entertaining, occasionally interfere with rational analysis. His position in Meta is particularly interesting for validating our own Meta thesis.